CarMax (NYSE:KMX – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Thursday, September 26th. Analysts expect the company to announce earnings of $0.84 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.
CarMax Price Performance
Shares of KMX stock opened at $76.50 on Wednesday. CarMax has a 1-year low of $59.66 and a 1-year high of $88.22. The stock’s 50-day moving average is $80.00 and its 200 day moving average is $76.40. The company has a market cap of $11.94 billion, a P/E ratio of 29.88, a PEG ratio of 1.53 and a beta of 1.69. The company has a debt-to-equity ratio of 2.95, a current ratio of 2.50 and a quick ratio of 0.60.
Analyst Ratings Changes
Several brokerages have weighed in on KMX. Argus raised CarMax to a “hold” rating in a report on Tuesday, June 25th. Mizuho decreased their target price on CarMax from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Tuesday, June 18th. Wedbush reaffirmed an “outperform” rating and set a $95.00 target price on shares of CarMax in a report on Tuesday, September 17th. Truist Financial lifted their target price on CarMax from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Monday. Finally, JPMorgan Chase & Co. lifted their target price on CarMax from $55.00 to $65.00 and gave the stock an “underweight” rating in a report on Thursday, September 19th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the stock. According to MarketBeat, CarMax presently has a consensus rating of “Hold” and an average price target of $77.50.
Insider Activity
In other news, CEO William D. Nash sold 120,000 shares of the business’s stock in a transaction that occurred on Thursday, July 11th. The stock was sold at an average price of $79.62, for a total value of $9,554,400.00. Following the completion of the sale, the chief executive officer now directly owns 181,683 shares in the company, valued at $14,465,600.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO William D. Nash sold 120,000 shares of CarMax stock in a transaction that occurred on Thursday, July 11th. The stock was sold at an average price of $79.62, for a total value of $9,554,400.00. Following the sale, the chief executive officer now directly owns 181,683 shares of the company’s stock, valued at $14,465,600.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Mohammad Shamim sold 25,000 shares of CarMax stock in a transaction on Friday, July 26th. The stock was sold at an average price of $82.26, for a total value of $2,056,500.00. Following the transaction, the executive vice president now owns 11,738 shares in the company, valued at approximately $965,567.88. The disclosure for this sale can be found here. Insiders sold 184,012 shares of company stock worth $14,803,843 over the last three months. 1.66% of the stock is currently owned by corporate insiders.
CarMax Company Profile
CarMax, Inc, through its subsidiaries, operates as a retailer of used vehicles and related products in the United States. It operates in two segments: CarMax Sales Operations and CarMax Auto Finance. The CarMax Sales Operations segment offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; used vehicle auctions; extended protection plans to customers at the time of sale; and reconditioning and vehicle repair services.
Featured Articles
- Five stocks we like better than CarMax
- How to Calculate Inflation Rate
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Are Growth Stocks and Investing in Them
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Consumer Staples Stocks, Explained
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for CarMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CarMax and related companies with MarketBeat.com's FREE daily email newsletter.